This trial explores rhodium-catalyzed reactions to create CF3-containing isoindolinones, suggesting new synthetic routes.
-substituted isoindolinones. This protocol is characterized by excellent chemo- and regioselectivities, a broad substrate scope, good functional group tolerance, and good to high yields.
No takes yet. Share an insight, caveat, or question.
Xue et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: